Literature DB >> 29217734

In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment.

Anne Helfen1, Johannes Roth2, Tony Ng3,4,5, Michel Eisenblaetter6,7.   

Abstract

Tumor development and growth, as well as metastatic spread, are strongly influenced by various, mostly innate, immune cells, which are recruited to the tumor site and driven to establish a specific tumor-supportive microenvironment. The contents of this microenvironment, such as myeloid cells, are a major factor in the overall prognosis of malignant disease, addressed by a constantly growing armament of therapeutic interventions targeting tumor-supportive immune cells. Current clinical imaging has long ignored the growing need for diagnostic approaches addressing these microenvironmental contents-approaches enabling a sensitive and specific classification of tumor immune crosstalk and the resulting tumor-associated immune cell activity. In this focus article we review the present status of, and promising developments in, the in vivo molecular imaging of tumor immune components designed to allow for inferences to be made on the cross-talk between tumor cells and the immune system. Current imaging modalities based on the infiltrating cell types are briefly discussed.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  in vivo imaging; tumor immunology; tumor microenvironment; tumor-induced inflammation

Mesh:

Year:  2017        PMID: 29217734     DOI: 10.2967/jnumed.117.198952

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.

Authors:  Anne Helfen; Nils Große Hokamp; Christiane Geyer; Walter Heindel; Christoph Bremer; Thomas Vogl; Carsten Höltke; Max Masthoff; Katarzyna Barczyk-Kahlert; Johannes Roth; Moritz Wildgruber; Michel Eisenblaetter
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 2.  Small molecules as theranostic agents in cancer immunology.

Authors:  Jindian Li; Juno Van Valkenburgh; Xingfang Hong; Peter S Conti; Xianzhong Zhang; Kai Chen
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 3.  Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents.

Authors:  Paola Ciciola; Priscilla Cascetta; Cataldo Bianco; Luigi Formisano; Roberto Bianco
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241

4.  S100A9-Imaging Enables Estimation of Early Therapy-Mediated Changes in the Inflammatory Tumor Microenvironment.

Authors:  Anne Helfen; Annika Schnepel; Jan Rieß; Miriam Stölting; Mirjam Gerwing; Max Masthoff; Thomas Vogl; Johannes Roth; Carsten Höltke; Moritz Wildgruber; Michel Eisenblätter
Journal:  Biomedicines       Date:  2021-01-03

Review 5.  Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.

Authors:  Amal Qattan
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

Review 6.  Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers.

Authors:  Rui Wei; Si Liu; Shutian Zhang; Li Min; Shengtao Zhu
Journal:  Anal Cell Pathol (Amst)       Date:  2020-01-08       Impact factor: 2.916

Review 7.  Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment.

Authors:  Tai-Na Wu; Hui-Ming Chen; Lie-Fen Shyur
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.